Novavax reported $303K in Interest Income for its fiscal quarter ending in December of 2021.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
AstraZeneca USD 73M 62M Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Cassava Sciences USD 1.17M 47K Sep/2025
Geron USD 4.26M 392K Sep/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
MannKind USD 2.63M 796K Sep/2025
Merck USD 69M 27M Dec/2025
Moderna USD 70M 3M Dec/2025
Novavax USD 303K 27K Dec/2021
Pfizer USD 166M 166M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025